186 related articles for article (PubMed ID: 19394098)
1. Spread-out antiproton beams deliver poor physical dose distributions for radiation therapy.
Paganetti H; Goitein M; Parodi K
Radiother Oncol; 2010 Apr; 95(1):79-86. PubMed ID: 19394098
[TBL] [Abstract][Full Text] [Related]
2. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams.
Bassler N; Kantemiris I; Karaiskos P; Engelke J; Holzscheiter MH; Petersen JB
Radiother Oncol; 2010 Apr; 95(1):87-93. PubMed ID: 20304512
[TBL] [Abstract][Full Text] [Related]
3. Antiproton radiotherapy.
Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
[TBL] [Abstract][Full Text] [Related]
4. An antiproton simulation study using MCNPX for radiation therapy.
Michael Handley S; Ahmad S
J Xray Sci Technol; 2011; 19(3):345-53. PubMed ID: 21876284
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
Titt U; Zheng Y; Vassiliev ON; Newhauser WD
Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
[TBL] [Abstract][Full Text] [Related]
6. Calculated LET spectrum from antiproton beams stopping in water.
Bassler N; Holzscheiter M
Acta Oncol; 2009; 48(2):223-6. PubMed ID: 18932095
[TBL] [Abstract][Full Text] [Related]
7. The biological effectiveness of antiproton irradiation.
Holzscheiter MH; Bassler N; Agazaryan N; Beyer G; Blackmore E; DeMarco JJ; Doser M; Durand RE; Hartley O; Iwamoto KS; Knudsen HV; Landua R; Maggiore C; McBride WH; Møller SP; Petersen J; Skarsgard LD; Smathers JB; Solberg TD; Uggerhøj UI; Vranjes S; Withers HR; Wong M; Wouters BG
Radiother Oncol; 2006 Dec; 81(3):233-42. PubMed ID: 17069916
[TBL] [Abstract][Full Text] [Related]
8. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
9. The relative biological effectiveness of antiprotons.
Holzscheiter MH; Alsner J; Bassler N; Boll R; Caccia M; Knudsen H; Maggiore C; Petersen JB; Sellner S; Straße T; Singers Sørensen B; Overgaard J
Radiother Oncol; 2016 Dec; 121(3):453-458. PubMed ID: 27988058
[TBL] [Abstract][Full Text] [Related]
10. Microdosimetric characteristics of proton beams from 50 keV to 200 MeV.
Chen J
Radiat Prot Dosimetry; 2011 Feb; 143(2-4):436-9. PubMed ID: 21177271
[TBL] [Abstract][Full Text] [Related]
11. The antiproton depth-dose curve in water.
Bassler N; Holzscheiter MH; Jäkel O; Knudsen HV; Kovacevic S
Phys Med Biol; 2008 Feb; 53(3):793-805. PubMed ID: 18199915
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 126 MeV antiproton and proton-a FLUKA-based microdosimetric approach.
Chattaraj A; Selvam TP
Phys Med Biol; 2022 Sep; 67(18):. PubMed ID: 35947988
[No Abstract] [Full Text] [Related]
13. Commissioning stereotactic radiosurgery beams using both experimental and theoretical methods.
Ding GX; Duggan DM; Coffey CW
Phys Med Biol; 2006 May; 51(10):2549-66. PubMed ID: 16675869
[TBL] [Abstract][Full Text] [Related]
14. A Monte Carlo study for the calculation of the average linear energy transfer (LET) distributions for a clinical proton beam line and a radiobiological carbon ion beam line.
Romano F; Cirrone GA; Cuttone G; Rosa FD; Mazzaglia SE; Petrovic I; Fira AR; Varisano A
Phys Med Biol; 2014 Jun; 59(12):2863-82. PubMed ID: 24828462
[TBL] [Abstract][Full Text] [Related]
15. The radiobiological and physical basis for radiotherapy with protons and heavier ions.
Kraft G
Strahlenther Onkol; 1990 Jan; 166(1):10-3. PubMed ID: 2154042
[TBL] [Abstract][Full Text] [Related]
16. V-79 Chinese hamster cells irradiated with antiprotons, a study of peripheral damage due to medium and long range components of the annihilation radiation.
Kovacevic S; Bassler N; Hartley O; Knudsen H; Vranjes S; Garaj-Vrhovac V; Holzscheiter M
Int J Radiat Biol; 2009 Dec; 85(12):1148-56. PubMed ID: 19995240
[TBL] [Abstract][Full Text] [Related]
17. Dual scattering foil design for poly-energetic electron beams.
Kainz KK; Antolak JA; Almond PR; Bloch CD; Hogstrom KR
Phys Med Biol; 2005 Mar; 50(5):755-67. PubMed ID: 15798252
[TBL] [Abstract][Full Text] [Related]
18. Dose and dose averaged LET comparison of ¹H, ⁴He, ⁶Li, ⁸Be, ¹⁰B, ¹²C, ¹⁴N, and ¹⁶O ion beams forming a spread-out Bragg peak.
Kantemiris I; Karaiskos P; Papagiannis P; Angelopoulos A
Med Phys; 2011 Dec; 38(12):6585-91. PubMed ID: 22149840
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo investigation of the low-dose envelope from scanned proton pencil beams.
Sawakuchi GO; Titt U; Mirkovic D; Ciangaru G; Zhu XR; Sahoo N; Gillin MT; Mohan R
Phys Med Biol; 2010 Feb; 55(3):711-21. PubMed ID: 20071752
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo simulations of a nozzle for the treatment of ocular tumours with high-energy proton beams.
Newhauser W; Koch N; Hummel S; Ziegler M; Titt U
Phys Med Biol; 2005 Nov; 50(22):5229-49. PubMed ID: 16264250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
